Kripa Poudel1, Amil M Shah2, Erin D Michos3, Aaron R Folsom1, Suma Konety4, Pamela L Lutsey5. 1. Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN, USA. 2. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. 3. Department of Medicine, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Division of Cardiology, University of Minnesota, Minneapolis, MN, USA. 5. Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN, USA. Electronic address: lutsey@umn.edu.
Abstract
BACKGROUND AND AIMS: Elevated serum calcium and phosphorus have been associated with increased risk of cardiovascular disorders. We evaluated whether abnormal calcium and high serum phosphorus are associated cross-sectionally with echocardiographic measures of left ventricular (LV) structure and function, as doing so may provide insight into the etiology of cardiac disorders. METHODS AND RESULTS: Included in the analysis were 5213 Atherosclerosis Risk in Communities Study (ARIC) participants who in 2011-2013 had echocardiography and serum calcium and phosphorus measurements. We evaluated the association of serum calcium (corrected for albumin) and phosphorus quintiles with measures of LV structure and function, after adjusting for other cardiovascular risk factors. Participants were on average 75.3 years old; 59.1% were female and 19.8% were African American. Mean (±SD) concentrations of calcium and phosphorus were 9.33 ± 0.38 and 3.46 ± 0.45 mg/dL, respectively. Higher calcium was associated with lower LV end-diastolic diameter (LVEDD) but greater prevalence of concentric remodeling (p-trend: 0.005 and 0.004 respectively). We observed association between high phosphorus and high septal E/e' (p-trend: 0.02). Likewise, higher serum phosphorus was associated with higher left atrial volume index (p-trend: 0.001) and LV hypertrophy prevalence (p-trend: 0.04). CONCLUSIONS: In conclusion, higher calcium was associated with more concentric remodeling but lower LVEDD, suggesting complex associations between calcium and cardiac function. Serum phosphorus was related to worse indices of LV diastolic function and LV hypertrophy, but not to LV systolic function. However, the magnitudes of association were modest, so clinical implications of these findings may be limited.
BACKGROUND AND AIMS: Elevated serum calcium and phosphorus have been associated with increased risk of cardiovascular disorders. We evaluated whether abnormal calcium and high serum phosphorus are associated cross-sectionally with echocardiographic measures of left ventricular (LV) structure and function, as doing so may provide insight into the etiology of cardiac disorders. METHODS AND RESULTS: Included in the analysis were 5213 Atherosclerosis Risk in Communities Study (ARIC) participants who in 2011-2013 had echocardiography and serum calcium and phosphorus measurements. We evaluated the association of serum calcium (corrected for albumin) and phosphorus quintiles with measures of LV structure and function, after adjusting for other cardiovascular risk factors. Participants were on average 75.3 years old; 59.1% were female and 19.8% were African American. Mean (±SD) concentrations of calcium and phosphorus were 9.33 ± 0.38 and 3.46 ± 0.45 mg/dL, respectively. Higher calcium was associated with lower LV end-diastolic diameter (LVEDD) but greater prevalence of concentric remodeling (p-trend: 0.005 and 0.004 respectively). We observed association between high phosphorus and high septal E/e' (p-trend: 0.02). Likewise, higher serum phosphorus was associated with higher left atrial volume index (p-trend: 0.001) and LV hypertrophy prevalence (p-trend: 0.04). CONCLUSIONS: In conclusion, higher calcium was associated with more concentric remodeling but lower LVEDD, suggesting complex associations between calcium and cardiac function. Serum phosphorus was related to worse indices of LV diastolic function and LV hypertrophy, but not to LV systolic function. However, the magnitudes of association were modest, so clinical implications of these findings may be limited.
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Carolyn S P Lam; Greg D Gamble; Lieng H Ling; David Sim; Kui Toh Gerard Leong; Poh Shuan Daniel Yeo; Hean Yee Ong; Fazlur Jaufeerally; Tze P Ng; Vicky A Cameron; Katrina Poppe; Mayanna Lund; Gerry Devlin; Richard Troughton; A Mark Richards; Robert N Doughty Journal: Eur Heart J Date: 2018-05-21 Impact factor: 29.983
Authors: Ravi Dhingra; Lisa M Sullivan; Caroline S Fox; Thomas J Wang; Ralph B D'Agostino; J Michael Gaziano; Ramachandran S Vasan Journal: Arch Intern Med Date: 2007-05-14
Authors: Mary R Rooney; James S Pankow; Shalamar D Sibley; Elizabeth Selvin; Jared P Reis; Erin D Michos; Pamela L Lutsey Journal: Am J Clin Nutr Date: 2016-08-10 Impact factor: 7.045
Authors: Armin Zittermann; Jana B Ernst; Sylvana Prokop; Uwe Fuchs; Jens Dreier; Joachim Kuhn; Cornelius Knabbe; Ingvild Birschmann; Uwe Schulz; Heiner K Berthold; Stefan Pilz; Ioanna Gouni-Berthold; Jan F Gummert; Marcus Dittrich; Jochen Börgermann Journal: Eur Heart J Date: 2017-08-01 Impact factor: 29.983
Authors: Wobo Bekwelem; Jeffrey R Misialek; Suma Konety; Scott D Solomon; Elsayed Z Soliman; Laura R Loehr; Faye L Lopez; Ervin R Fox; Thomas H Mosley; Alvaro Alonso Journal: PLoS One Date: 2014-10-16 Impact factor: 3.240